atorvastatin has been researched along with phosphorus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horiuchi, N; Kawane, T; Kurahashi, I; Terashima, S; Yanagawa, T; Yoshida, H | 1 |
| Abad, L; de Luis, D; Duenas-Laita, A; Gonzalez Sagredo, M; Pérez-Castrillón, JL; Sanz-Cantalapiedra, A; Vega, G | 1 |
| Chang, B; Chen, L; Fang, P; Li, H; Lu, S; Yang, J | 1 |
3 other study(ies) available for atorvastatin and phosphorus
| Article | Year |
|---|---|
Atorvastatin enhances bone density in ovariectomized rats given 17beta-estradiol or human parathyroid hormone(1-34).
Topics: Animals; Atorvastatin; Bone Density; Calcium; Estradiol; Female; Femur; Heptanoic Acids; Humans; Injections, Subcutaneous; Lumbar Vertebrae; Ovariectomy; Parathyroid Hormone; Peptide Fragments; Phosphorus; Pyrroles; Rats; Rats, Sprague-Dawley | 2004 |
Effect of the TNFalpha-308 G/A polymorphism on the changes produced by atorvastatin in bone mineral density in patients with acute coronary syndrome.
Topics: Absorptiometry, Photon; Acute Coronary Syndrome; Amino Acids; Anticholesteremic Agents; Atorvastatin; Bone Density; Calcium; Cholesterol; Dose-Response Relationship, Drug; Female; Femur Neck; Follow-Up Studies; Genotype; Heptanoic Acids; Humans; Magnesium; Male; Middle Aged; Osteocalcin; Osteoporosis; Phosphorus; Polymerase Chain Reaction; Polymorphism, Genetic; Pyrroles; Risk Factors; Triglycerides; Tumor Necrosis Factor-alpha | 2008 |
Effects of atorvastatin on bone metabolism and bone mineral density in Wistar rats.
Topics: Alkaline Phosphatase; Animals; Atorvastatin; Biomarkers; Bone and Bones; Bone Density; Bone Development; Calcium; Creatine; Dose-Response Relationship, Drug; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Male; Phosphorus; Pyrroles; Rats; Rats, Wistar | 2011 |